Melatonin Zentiva

Melatonin, the active ingredient in Melatonin Zentiva, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps regulate circadian rhythm and is used to manage insomnia, jet lag and sleep‑wake rhythm disorders in adults.

GNH USA supplies Melatonin Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice and provides the product to a broad network of healthcare providers across multiple regions, ensuring consistent quality and regulatory compliance.

Melatonin acts on melatonin receptors to support normal sleep regulation. - Insomnia: helps shorten sleep onset latency and improve sleep continuity. - Jet lag: assists in adjusting the internal clock to new time zones, reducing fatigue. - Sleep‑wake rhythm disorders: supports alignment of sleep patterns with desired schedules.

Melatonin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Drowsiness: feeling of sleepiness during the day. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness. - Gastrointestinal discomfort: nausea or abdominal cramps.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or vivid dreams.

When considering melatonin therapy, several precautions should be observed to ensure safe use. - Consult healthcare provider: discuss underlying sleep disorders and other medications. - Pregnancy and breastfeeding: use only if clearly needed and after professional advice. - Chronic conditions: evaluate liver or kidney impairment before use. - Timing of administration: take shortly before desired bedtime to align with circadian rhythm. - Avoid driving: if residual drowsiness occurs, refrain from operating machinery. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Melatonin may interact with other substances that affect its metabolism or sleep‑wake cycle.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk; monitor INR closely. - Immunosuppressants: potential reduction in efficacy; consult physician.

Moderate Interactions (Monitor Closely): - CYP1A2 inhibitors (e.g., fluvoxamine): can raise melatonin levels, watch for excessive sedation. - CNS depressants (e.g., benzodiazepines): additive sleepiness, adjust dose if needed. - Oral contraceptives: may elevate melatonin concentrations, monitor response.